Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
IGM Biosciences, Inc. (IGMS)
|
Add to portfolio |
|
|
|
| Price: |
$27.21
| | Metrics |
| OS: |
58.4
|
M
| |
|
|
| Market cap: |
$1.59
|
B
| |
|
|
|
Net cash:
|
$151
|
M
| |
$2.58
|
per share
|
|
EV:
|
$1.44
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Selling, general and administrative | 165.3 | 83.3 | 44.5 | | |
| Research and development | | | | 19.0 | 8.6 |
| General and administrative | | | | 3.8 | 2.5 |
| EBIT | -165.0 | -79.4 | -41.8 | -22.8 | -11.1 |
| Pre-tax income | -165.2 | -81.4 | -43.1 | -22.7 | -11.1 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -165.2 | -81.4 | -43.1 | -22.7 | -11.1 |
| |
| Diluted EPS | ($4.93) | ($2.65) | ($4.80) | ($51.84) | ($25.24) |
| Shares outstanding (diluted) | 33.5 | 30.7 | 9.0 | 0.4 | 0.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|